Skip to content

   Pharma Publications

Neuropsychopharmacology
  • A neural pathway integrating stress and feeding
    Published on 2024-05-24
    2 years ago
  • Placebo response in RCT for antidepressant may not always be the ‘villain’ to fight: are KOR antagonists possibly affecting the intrinsic placebo response?
    Published on 2024-05-23
    2 years ago
  • Resting state functional brain connectivity in child and adolescent psychiatry: where are we now?
    Published on 2024-05-22
    2 years ago
  • Parvalbumin interneuron mGlu5 receptors govern sex differences in prefrontal cortex physiology and binge drinking
    Published on 2024-05-21
    2 years ago
  • Endocannabinoids and related lipids linked to social exclusion in individuals with chronic non-medical prescription opioid use
    Published on 2024-05-21
    2 years ago
  • In memoriam: Arthur J. Prange, Jr., MD
    Published on 2024-05-21
    2 years ago
  • Temporal dissociation between local and global functional adaptations of the maternal brain to childbirth: a longitudinal assessment
    Published on 2024-05-20
    2 years ago
« Previous 1 … 57 58 59 60 61 … 143 Next »
Journal of Psychopharmacology
  • Clinical correlates of early onset antipsychotic treatment resistance
    Published on 2022-10-21
    3 years ago
  • Validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview among outpatients with schizophrenia
    Published on 2022-10-21
    3 years ago
  • Therapeutic (Sub)stance: Current practice and therapeutic conduct in preparatory sessions in substance-assisted psychotherapy—A systematized review
    Published on 2022-10-20
    3 years ago
  • D2-like receptor activation by intranasal dopamine attenuates fear responses induced by electrical stimulation of the dorsal periaqueductal grey matter, but fails to reduce aversion to pit vipers and T-maze performance
    Published on 2022-10-14
    3 years ago
  • Efficacy of aripiprazole as adjunctive therapy in major depressive disorder with somatic symptoms: A randomized, double-blind, placebo-controlled trial with clinical and electroencephalography evidence
    Published on 2022-10-14
    3 years ago
  • Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze
    Published on 2022-10-14
    3 years ago
  • Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration–effect relations using the IB-de-risk tool
    Published on 2022-10-14
    3 years ago
« Previous 1 … 57 58 59 60 61 … 134 Next »
European Neuropsychopharmacology
  • Higher lymphocyte count associated with larger hippocampal volume and fewer depressive symptoms in drug–na ïve first-episode psychosis
    Published on 2023-01-28
    3 years ago
  • Number needed to treat and number needed to harm: What are they good for?
    Published on 2023-01-27
    3 years ago
  • Multi-omics data integration methods and their applications in psychiatric disorders
    Published on 2023-01-26
    3 years ago
  • LSD and language: Decreased structural connectivity, increased semantic similarity, changed vocabulary in healthy individuals
    Published on 2023-01-20
    3 years ago
  • As in cooking, so in medicine: Doses do matter
    Published on 2023-01-15
    3 years ago
  • Cognitive and clinical correlates of resting-state fMRI in adults with gambling disorder
    Published on 2023-01-13
    3 years ago
  • The efficacy of lumateperone on symptoms of depression in bipolar I and bipolar II disorder: Secondary and post hoc analyses
    Published on 2023-01-13
    3 years ago
« Previous 1 … 57 58 59 60 61 … 154 Next »

   Pharma Pub